Company Filing History:
Years Active: 2016-2022
Title: The Innovations of Roberto Chiarle
Introduction
Roberto Chiarle is a prominent inventor based in Brookline, MA (US). He has made significant contributions to the field of immunology, particularly in the development of advanced genetic editing techniques. With a total of 3 patents to his name, Chiarle's work has the potential to revolutionize treatments for various diseases.
Latest Patents
Chiarle's latest patents include groundbreaking technologies such as the "Customized class switch of immunoglobulin genes in lymphoma and hybridoma by CRISPR/CAS9 technology." This patent provides genetically modified antibody-producing cells that have edited chromosomal sequences associated with the immunoglobulin heavy chain constant region. The cells are generated using a CRISPR/Cas 9-mediated editing process, which allows for precise modifications. Another notable patent is the "High throughput genome-wide translocation sequencing," which outlines methods for high-throughput screening to determine the locations of double-stranded DNA breaks and translocations in genomes caused by various agents, including enzymes.
Career Highlights
Chiarle is currently affiliated with the Children's Medical Center Corporation, where he continues to push the boundaries of genetic research. His innovative approaches have garnered attention in the scientific community and have paved the way for new therapeutic strategies.
Collaborations
Chiarle has collaborated with esteemed colleagues such as Frederick W Alt and Monica Gostissa. These partnerships have further enhanced the impact of his research and innovations.
Conclusion
Roberto Chiarle's contributions to the field of immunology through his patents and research are noteworthy. His work exemplifies the potential of genetic editing technologies in advancing medical science.